Valuation Colinz Laboratories Limited

Stocks

Market Closed - Bombay S.E. 08:02:33 01/10/26 pm AEST			5-day change	1st Jan Change
73.50 ^INR	-4.16%		-3.54%	+37.05%

20/08	Annjana Dugar, Likhitta Dugar and Antariksh Dugar completed the acquisition of an additional 0.000238% stake in Colinz Laboratories Limited for INR 324.	CI
30/07	Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	34.74	107.6	160	94.59	182.5	112.1
Change	-	209.87%	48.62%	-40.87%	92.92%	-38.57%
Enterprise Value (EV) ¹	-2.149	60.43	105.4	30.29	133.4	30.71
Change	-	2,911.96%	74.47%	-71.27%	340.39%	-76.98%
P/E	16.7x	31.8x	19.2x	19.5x	36.8x	21.8x
PBR	0.48x	1.4x	1.08x	1.06x	1.93x	1.12x
PEG	-	0.5x	0x	3.23x	17.76x	6.14x
Capitalization / Revenue	0.56x	1.54x	2.24x	1.35x	2.8x	1.83x
EV / Revenue	-0.03x	0.87x	1.47x	0.43x	2.04x	0.5x
EV / EBITDA	-0.65x	10.3x	16.7x	5.58x	26.9x	7.54x
EV / EBIT	-1.52x	15.7x	20.9x	7.34x	36.7x	12.2x
EV / FCF	-0.2x	8.87x	17.8x	4.12x	-7.62x	1.07x
FCF Yield	-506%	11.3%	5.62%	24.3%	-13.1%	93%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.4541	0.74	1.82	1.93	1.97	2.04
Distribution rate	-	-	-	-	-	-
Net sales ¹	61.59	69.74	71.55	70.3	65.28	61.36
EBITDA ¹	3.331	5.862	6.326	5.428	4.951	4.075
EBIT ¹	1.418	3.85	5.037	4.125	3.639	2.512
Net income ¹	2.076	3.393	4.574	4.867	4.966	5.145
Net Debt ¹	-36.89	-47.22	-54.55	-64.3	-49.09	-81.39
Reference price ²	7.60	23.55	35.00	37.55	72.44	44.50
Nbr of stocks (in thousands)	4,571	4,571	4,571	2,519	2,519	2,519
Announcement Date	30/8/21	24/8/22	29/8/23	29/8/24	28/8/25	20/8/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
COLINZ LABORATORIES LIMITED	-	-	-	-	1.93M
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.27x	2.29%	369.72B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%